Genetic polymorphism of opioid receptors and use of opioid substances by high school students of Cotonou and Parakou (Benin)
DOI:
https://doi.org/10.30574/gscarr.2021.9.3.0303Keywords:
Receptors, Opioid, Polymorphism, Teenagers, Young adultsAbstract
In Benin, schools become sometimes the hub for dealing and consuming psychoactive substances; opioids in particular. The objectives of this study are to identify the risk factors related to the use of opioids and investigate the genetic polymorphism of mu and delta opioid receptors of teenagers and young adults who consume opioids in schools. To accomplish this, 453 students participated in this study; R diversity 3.6.1 software in the RStudio environment was used to identify students who experience opioids through ASSIST V3.0 scoring. SNPs A118G on the OPRM gene (µ) and T921C on the OPRD gene (d), were searched by PCR on DNA extracts from peripheral blood of individuals. We identified 54 regular opioid users and 399 non users. This experience begins for most with the consumption of alcohol and tobacco and is facilitated by the proximity of marshlands, kiosks, and pubs near high schools and colleges. The aggressive advertisement combined with relative socio-cultural tolerance just worsen this behavioral deviance. We found no difference in the SNP frequencies of the OPRM (µ) and OPRD (d) genes between students opioids consumers and non-consumers.
Metrics
References
Kpozehouen A, Ahanhanzo YG, Paraïso MN, Munezero F, Saizonou JZ, Makoutodé M, et al. Factors associated whith the use of psychoactive substances in young people in Bénin. Sante Publique (Paris). 2015; 27(6): 871–80.
Nikiéma L, Kouanda S, Seck I, Tiendrebéogo S, Ouédraogo HG. Psycho active drugs use among secondary schools in Ouagadougou : Prevalence and risk factors Cadre de l ’ étude. Sci Tech Sci la santé. 2011; 34: 65–82.
Adounkpe F, Behanzin L, Teclessou JN KCA. Predictors of medicines and addictive substances use in private secondary schools by adolescents in Cotonou, 2016, Benin. J Rech Sci Univ Lomé. 2018; 20(3): 257–70.
Beck F, Dervaux A, Roscoät E Du, Grall-bronnec M, Kern L, Krebs M, et al. Addictive conducts in adolescents: Uses, prevention and support. Paris: INSREM. 2019.
Duaux E, Krebs MO, Loo H, Poirier MF. Genetic vulnerability to drug abuse. Eur Psychiatry. 2000; 15(2): 109–14.
Kreek MJ, Bart G, Lilly C, Laforge KS, Nielsen DA. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev. 2005; 57(1): 1–26.
Albonaim A, Fazel H, Sharafshah A, Omarmeli V. Association of OPRK1 gene polymorphisms with opioid dependence in addicted male individuals undergoing methadone treatment in an Iranian population. J Addict Dis. August 2017; 0887.
Crist RC, Doyle GA, Kampman KM, Berrettini WH. A delta-opioid receptor genetic variant is associated with abstinence prior to and during cocaine dependence treatment. Drug Alcohol Depend. 2016; 166: 268–71.
Aracil P. Is there a genetic predisposition to heroin addiction? [PhD These]. HAL. Université Joseph Fourier; 2014.
Marsousi N, Ancrenaz V, Daali Y, Rudaz S, Samer C, Desmeules J. Influence of genetic polymorphisms on the variability of opioid response. Douleur Analg. 2013; 26(4): 203–8.
Gelernter J, Kranzler HR. Variant detection at the δ opioid receptor (OPRD1) locus and population genetics of a novel variant affecting protein sequence. Hum Genet. 2000; 107(1): 86–8.
Roche-Xavier L, Barreau M, Chatti I, Libert F, Boulamery A, Authier N. Pharmacogenetics, addiction and opioids. Douleur Analg. 2013; 26(4): 226–33.
OMS. Outil Assist V3.0. 2007.
Chomczynski P, Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: Twenty-something years on. Nat Protoc. 2006; 1(2): 581–5.
Buvoli M, Langer SJ, Bialik S, Leinwand LA. Potential limitations of transcription terminators used as transgene insulators in adenoviral vectors. Gene Ther. 2002; 9(3): 227–31.
Asl SS, Roointan A, Bergen H, Amiri S, Mardani P, Ashtari N, et al. Opioid Receptors gene polymorphism and heroin dependence in Iran. Basic Clin Neurosci. 2018; 9(2): 101–6.
Deepak Kumar et al. Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population. Prog Neuro-Psychopharmacology Biol Psychiatry. 2012; 36(2): 225–30.
Famuyiwa O, Aina OF, Bankole-Oki OM. Epidemiology of psychoactive drug use amongst adolescents in metropolitan Lagos, Nigeria. Eur Child Adolesc Psychiatry. 2011; 20(7): 351–9.
Adekeye OA, Adeusi SO, Chenube OO, Ahmadu FO, Sholarin MA. Assessment of Alcohol and Substance Use among Undergraduates in Selected Private Universities in Southwest Nigeria. IOSR J Humanit Soc Sci Ver II. 2015; 20(3): 1–7.
Zarrouq B. Epidemiological and toxicological profile of psychoactive substance use and suicidal behaviour among Moroccan adolescents. [PhD These]. ResearchGate. Université Sidi Mohammed Ben Abdellah. 2016.
Ming D. Li and Margit Burmeister. New insights into the genetics of addiction. Nat REVEWs | Genet | Genet. 2009; 10(9): 225–33.
Bond C, Laforge KS, Tian M, Melia D, Zhang S, Borg L, et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction. Proc Natl Acad Sci U S A. 1998; 95(16): 9608–13.
Beer B, Erb R, Pavlic M, Ulmer H, Giacomuzzi S, Riemer Y, et al. Association of Polymorphisms in Pharmacogenetic Candidate Genes (OPRD1, GAL, ABCB1, OPRM1) with Opioid Dependence in European Population: A Case-Control Study. PLoS One. 2013; 8(9): 1–7.
Shakiba M, Hashe M, Rahbari Z, Mahdar S. Lack of Association between Human µ-Opioid Receptor ( OPRM1 ) Gene Polymorphisms and Heroin Addiction in A Sample of Southeast Iranian Population. AIMS Med Sci. May 2017; 4: 233–40.
Soleimani AS, Amir R, Hugo B, Amiri S, Parastoo M, Niloufar A, et al. Opioid Receptors gene polymorphism and heroin dependence in Iran. Basic Clin Neurosci. 2018; 9(2): 101–6.
Francés F, Portolés O, Castelló A, Costa JA, Verdú F. Association between opioid receptor mu 1 (OPRM1 ) gene polymorphisms and tobacco and alcohol consumption in a Spanish population. Bosn J Basic Med Sci. 2015; 1.
William V. et al. Influence of the A118G polymorphism of the OPRM1 gene and exon 3 VNTR polymorphism of the DRD4 gene on cigarette craving after alcohol administration. Nicotine Tob Res Adv. 2015; 1–12.
Bart G, Heilig M, LaForge KS, Pollak L, Leal SM, Ott J, et al. Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Mol Psychiatry. 2004; 9(6): 547-549+542.
Vadasz C, Saito M, Gyetvai B, Mikics E, Vadasz C. Scanning of five chromosomes for alcohol consumption loci. Alcohol. 2000; 22(1): 25–34.
Saito M, Ehringer MA, Toth R, Oros M, Szakall I, Sikela JM, et al. Variants of κ-opioid receptor gene and mRNA in alcohol-preferring and alcohol-avoiding mice. Alcohol. 2003; 29(1): 39–49.
Zhang H, Kranzler HR, Yang BZ, Luo X, Gelernter J. The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Mol Psychiatry. 2008; 13(5): 531–43.
Crist R, Ambrose-Lanci MV L. et al. Case-control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations. NIH Public Acess. 2014; 127: 122–8.
Lötsch J, Geisslinger G, Tegeder I. Genetic modulation of the pharmacological treatment of pain. Pharmacol Ther. 2009; 124(2): 168–84.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.